High-dose, prescription-grade fish oil can reduce certain types of arterial plaque, but the standard fish oil capsules from a drugstore shelf almost certainly won’t have the same effect. The critical distinction lies in the type of omega-3, the dose, and the purity of the product. Clinical trials using 4 grams per day of a purified form of EPA (one specific omega-3 fatty acid) have shown measurable plaque shrinkage, while lower doses and mixed supplements have not demonstrated the same results.
What the Strongest Evidence Shows
The most direct evidence for plaque reduction comes from a trial called EVAPORATE, which used CT imaging to track plaque changes in people with elevated triglycerides already taking statins. After 18 months, participants taking 4 grams daily of purified EPA saw a 17% reduction in low-attenuation plaque volume. Low-attenuation plaque is the soft, unstable type most likely to rupture and cause a heart attack. Meanwhile, the placebo group’s low-attenuation plaque volume more than doubled over the same period, increasing by 109%.
Total plaque volume was also lower in the treatment group. Harvard Health Publishing described these results as showing the drug “helps shrink plaque in heart arteries,” not just slow its growth. A separate Japanese trial examining the same compound alongside a statin also found evidence of plaque regression using ultrasound imaging inside coronary arteries.
How Omega-3s Affect Plaque
Omega-3 fatty acids influence arterial plaque through several pathways. When EPA gets incorporated into the walls of plaques, it reduces inflammation inside them and thickens the fibrous cap that holds plaque together. A thicker cap means a more stable plaque, one less likely to rupture and trigger a clot. This structural remodeling is one of the most important effects, because it’s unstable plaque, not plaque size alone, that causes most heart attacks.
At the cellular level, omega-3s dial down the inflammatory machinery inside artery walls. They reduce the production of reactive oxygen species (molecules that damage tissue) and suppress a key inflammatory switch called NF-κB in immune cells called macrophages. EPA and DHA also generate anti-inflammatory compounds called resolvins and protectins, which actively help resolve ongoing inflammation rather than just blocking it. These effects combine to slow plaque growth and make existing plaque less dangerous.
Plaque Reduction vs. Calcium Score
If you’ve had a coronary artery calcium (CAC) scan, you might wonder whether fish oil can lower that number. The answer, based on current evidence, is no. A 30-month trial gave patients with coronary artery disease about 3.4 grams of combined EPA and DHA daily alongside statins. Both the omega-3 group and the control group saw significant increases in calcium scores, with no meaningful difference between them. This held true regardless of starting calcium level, statin intensity, or how much omega-3 patients actually absorbed.
This doesn’t contradict the plaque-shrinking findings. Calcium scores measure hard, calcified plaque, which is actually the more stable type. The benefits of omega-3s appear concentrated on soft, inflammatory plaque. So your CAC score is not the right test to track omega-3’s effects on your arteries.
Cardiovascular Event Reduction
Beyond imaging studies, there’s large-scale outcome data. A trial of over 8,000 patients with elevated triglycerides on statin therapy found that 4 grams of purified EPA daily reduced the rate of major cardiovascular events by 25%. The primary composite endpoint, which included cardiovascular death, heart attack, stroke, and hospitalization for unstable chest pain, occurred in 17.2% of the treatment group compared to 22% of the placebo group. Cardiovascular deaths specifically dropped from 5.2% to 4.3%.
The American Heart Association’s science advisory highlights these results as support for using 4 grams daily of EPA in patients with high triglycerides who are already on a statin. This is a prescription product taken under medical supervision, not an over-the-counter recommendation.
Store-Bought Supplements Are Not the Same
This is where many people get misled. The trials showing plaque reduction and fewer heart attacks used a pharmaceutical-grade, FDA-regulated product containing only purified EPA at a specific dose. Over-the-counter fish oil supplements are a different category entirely.
Testing of retail fish oil capsules has revealed significant problems. In one analysis of 32 fish oil products sold in New Zealand, only 3 contained EPA and DHA levels matching their labels. The majority had less than 67% of the stated content. Beyond quantity issues, supplements may contain contaminants, cholesterol, saturated fats, and oxidation byproducts. EPA and DHA together often make up less than 75% of the total fat in a supplement capsule, with the rest being other fats you didn’t intend to take.
Prescription omega-3 products are held to strict FDA purity and potency standards. They contain exactly what the label says, in a highly concentrated form. A typical store-bought fish oil capsule contains around 300 mg of combined EPA and DHA, meaning you’d need to swallow roughly 13 capsules to approach the 4-gram EPA dose used in clinical trials, and you’d be ingesting a significant amount of unwanted fats and potential contaminants along the way.
The Triglyceride Connection
Omega-3s lower triglycerides, and this matters for plaque. At prescription doses (2 to 4 grams per day), EPA and DHA reduce triglycerides by 20% to 40%. In the major cardiovascular outcomes trial, the treatment group saw a placebo-adjusted triglyceride drop of about 20%, along with reductions in other lipid markers: non-HDL cholesterol fell by about 12%, and a protein linked to plaque buildup (apolipoprotein B) dropped by nearly 10%.
High triglycerides promote fat deposition in artery walls and fuel the inflammatory processes that make plaque grow and destabilize. By lowering triglycerides, omega-3s remove one of the drivers of plaque progression. But the benefits of purified EPA appear to go beyond triglyceride lowering alone, since the reduction in heart attacks and strokes was larger than triglyceride changes alone would predict.
Potential Risks at High Doses
High-dose omega-3 supplementation is not risk-free. A 2021 review of seven studies published in Circulation found an increased risk of atrial fibrillation (an irregular heart rhythm) among people taking omega-3 supplements. One large study found that healthy people who regularly used fish oil supplements were 13% more likely to develop atrial fibrillation compared to non-users. This risk appears more relevant at the higher doses used in clinical trials (4 grams per day) than at the 1-gram range recommended for general heart health.
What This Means in Practice
The AHA recommends all adults eat fatty fish at least twice a week. For people with documented coronary heart disease, the recommendation is about 1 gram of combined EPA and DHA daily, obtainable through diet or supplements. For people with very high triglycerides (500 mg/dL or above), prescription omega-3 products at 2 to 4 grams per day are a recognized treatment option, and the AHA advises that anyone taking more than 3 grams daily from supplements should do so under medical supervision.
If your goal is specifically reducing dangerous plaque in your arteries, the evidence points toward high-dose, purified EPA as a prescription medication, not a handful of drugstore capsules. The plaque regression seen in trials was achieved with a pharmaceutical product, in people already on statins, at doses that require a prescription. Eating fish regularly and taking a standard fish oil supplement may offer modest cardiovascular benefits, but expecting them to shrink existing plaque is not supported by the current evidence.